All News

Hypertension and obstructive sleep apnea are considered independent risk factors for cardiovascular diseases as well as diabetes.

Female pharmacists make up approximately 62% of the pharmacy workforce. They want, and in many cases demand, a good work-life balance.

Jenna Anderson, CEO of KiHealth Inc, and Amanda Wiley, marketing manager of HealthSource Marketing, discuss the evolving role of pharmacies in at-home testing.

Micah Cost, PharmD, MS, CAE, CEO of the Pharmacy Quality Alliance, hosted the keynote session at the Total Pharmacy Solutions Summit Spring 2025 event.

Stephanie Downing, MBA, discusses expanding pharmacy services, clinical workflow efficiency, and revenue growth, highlighting the shift from traditional pharmacy roles to providing expanded clinical services.

In an update to the Journal of Pain Research’s formative meta-analysis on pain management in the US, researchers focused on the racial and ethnic disparities in access to pain treatment.

The drug shows a decrease in proteinuria and is well tolerated and safe, including for Black patients with chronic kidney disease.

Expert on pain medicine, Mark Garofoli, PharmD, BCGP, CPE, CTTS, joined Drug Topics to discuss trends in the safety and efficacy of OTC pain medications and what products patients often seek at the pharmacy.

Data from the HERCULES phase 3 trial were presented at the 2025 Annual Meeting for the American Academy of Neurology for non-relapsing secondary progressive multiple sclerosis.

VAX-24 elicited substantial immunoglobulin G (IgG) and opsonophagocytic assay (OPA) immune responses at 1-month after the third dose across all doses studied.

There were no statistically significant differences between cognitive behavioral therapy and mindfulness-based therapy in reducing the dosage for chronic lower back pain.

In a comprehensive review, researchers aimed to explore seasonality, environmental factors, and the genetic and epigenetic mechanisms of patients living with psoriasis vulgaris.

Further studies are needed to further confirm the association between glucagon-like peptide 1 medication and reductions in dementia risk.

In a review of skin inflammation’s link to food allergen sensitivity, researchers explored how patients with atopic dermatitis may be more susceptible to the development of food allergies.

In part 3 of our interview with Jenny Markell, BA, she discussed drug advertising trends among Alzheimer’s disease drugs and how FDA suggestions are not necessarily followed.

Conflicting study findings show various associations between asthma and COVID-19; further data are needed.

Technology, such as continuous glucose monitors, changes the way patients are treated, but more work needs to be done for racial, ethnic, and socioeconomic disparities.

Researchers explored various types of self-expression among pharmacists and how they were associated with experience in community pharmacy-led deprescribing.

This year’s conference is taking place from April 10 to 12 in Austin, Texas.

Texas reports over 480 cases of measles and 2 measles-related deaths, with 1 including an unvaccinated pediatric patient.

In a conversation with David Blair, CEO of LucyRx, he discussed his company’s unique business model and how it is giving back to patients, providers, and plan sponsors alike.

Type 1 diabetes can cause long-term complications, including the development of autoimmune diseases.

Technological evolution promises to enhance patient care, reduce errors, and provide intelligent support that augments human expertise rather than replacing it.

Clinical pharmacists counsel patients during the intervention and make informed medication changes based on the data received from continuous glucose monitoring (CGM).

Pharmacists can also provide education across all pillars of health, including exercise, wellness, and dietary changes.

Researchers conducted a study to understand how community pharmacist referrals translated to the acceptance and completion of annual wellness visits.

Patients treated with the therapy showed significantly less progression of structural damage compared to patients who received placebo at week 24.

Jenny Markell, BA, discussed the ongoing trends in prescription drug advertising and touched on her research into the impact it has on consumers.